These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 35997335)

  • 1. Multiple Asparaginase Infusions Cause Increasingly Severe Acute Hyperammonemia.
    Buddington RK; Buddington KK; Howard SC
    Med Sci (Basel); 2022 Aug; 10(3):. PubMed ID: 35997335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ammonia level as a proxy of asparaginase inactivation in children: A strategy for classification of infusion reactions.
    Santos AC; Land MGP; Lima EC
    J Oncol Pharm Pract; 2022 Apr; 28(3):551-559. PubMed ID: 33645327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Molecular basis of hyperammonemia secondary to asparaginase: from therapeutic efficacity to toxicity].
    Gallin M; Damaj L; Gandemer V; Bendavid C; Moreau C
    Ann Biol Clin (Paris); 2023 Oct; 81(4):365-377. PubMed ID: 37864442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment and outcomes of symptomatic hyperammonemia following asparaginase therapy in children with acute lymphoblastic leukemia.
    Lee A; Eldem I; Altintas B; Nguyen H; Willis D; Langley R; Shinawi M
    Mol Genet Metab; 2023 Jul; 139(3):107627. PubMed ID: 37327713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperammonemia secondary to asparaginase: A case series.
    Nussbaum V; Lubcke N; Findlay R
    J Oncol Pharm Pract; 2016 Feb; 22(1):161-4. PubMed ID: 25245038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transient hyperammonemia due to L-asparaginase therapy in children with acute lymphoblastic leukemia or non-Hodgkin lymphoma.
    Jörck C; Kiess W; Weigel JF; Mütze U; Bierbach U; Beblo S
    Pediatr Hematol Oncol; 2011 Feb; 28(1):3-9. PubMed ID: 20615069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Symptomatic hyperammonemia secondary to recombinant Erwinia asparaginase.
    Martin CE; Kohorst MA; Ferdjallah A; Kalmes JL; Johnson HM; Galardy PJ; Khan SP; Kuhn AK
    Pediatr Blood Cancer; 2023 May; 70(5):e30208. PubMed ID: 36633209
    [No Abstract]   [Full Text] [Related]  

  • 8. Hypersensitivity reactions to L-asparaginase do not impact on the remission duration of adults with acute lymphoblastic leukemia.
    Larson RA; Fretzin MH; Dodge RK; Schiffer CA
    Leukemia; 1998 May; 12(5):660-5. PubMed ID: 9593262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differentiating hypersensitivity versus infusion-related reactions in pediatric patients receiving intravenous asparaginase therapy for acute lymphoblastic leukemia.
    Burke MJ; Rheingold SR
    Leuk Lymphoma; 2017 Mar; 58(3):540-551. PubMed ID: 27546298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes Following Discontinuation of E. coli l-Asparaginase Upon Severe Allergic Reactions in Children With Acute Lymphoblastic Leukemia.
    Yen HJ; Chang WH; Liu HC; Yeh TC; Hung GY; Wu KH; Peng CT; Chang YH; Chang TK; Hsiao CC; Sheen JM; Chao YH; Chang TT; Chiou SS; Lin PC; Wang SC; Lin MT; Ho WL; Chen YC; Liang DC
    Pediatr Blood Cancer; 2016 Apr; 63(4):665-70. PubMed ID: 26703788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The toxicity of very prolonged courses of PEGasparaginase or Erwinia asparaginase in relation to asparaginase activity, with a special focus on dyslipidemia.
    Tong WH; Pieters R; de Groot-Kruseman HA; Hop WC; Boos J; Tissing WJ; van der Sluis IM
    Haematologica; 2014 Nov; 99(11):1716-21. PubMed ID: 25150254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Symptomatic Hyperammonemia With Erwinia chrysanthemi-derived Asparaginase in Pediatric Leukemia Patients.
    Gossai N; Richards M; Boman L; Messinger Y; Gernbacher S; Perkins J; Bostrom B
    J Pediatr Hematol Oncol; 2018 May; 40(4):312-315. PubMed ID: 29334534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma ammonia concentration after L-asparaginase therapy in 27 dogs with high-grade lymphoma or leukemia.
    Speas AL; Lyles SE; Wirth KA; Fahey CE; Kow K; Lejeune AT; Milner RJ
    J Vet Emerg Crit Care (San Antonio); 2018 Mar; 28(2):130-139. PubMed ID: 29469204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of immunologic crossreaction of antiasparaginase antibodies in acute lymphoblastic leukemia (ALL) and lymphoma patients.
    Wang B; Relling MV; Storm MC; Woo MH; Ribeiro R; Pui CH; Hak LJ
    Leukemia; 2003 Aug; 17(8):1583-8. PubMed ID: 12886246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypersensitivity reactions to asparaginase therapy in acute lymphoblastic leukemia: immunology and clinical consequences.
    Burke MJ; Zalewska-Szewczyk B
    Future Oncol; 2022 Mar; 18(10):1285-1299. PubMed ID: 35107320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [New possibilities of treatment with PEG-L-asparaginase in patients with acute lymphoblastic leukemia sensitized to l-asparaginase E.coli and erwinase].
    Sikorska-Fic B; Makowska K; Rokicka-Milewska R
    Wiad Lek; 1998; 51 Suppl 4():233-6. PubMed ID: 10731974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of Erwinia asparaginase for adult patients with acute lymphoblastic leukemia after pegaspargase intolerance.
    Horvat TZ; Pecoraro JJ; Daley RJ; Buie LW; King AC; Rampal RK; Tallman MS; Park JH; Douer D
    Leuk Res; 2016 Nov; 50():17-20. PubMed ID: 27631159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute central nervous system complications and ammonium levels in adult patients with acute lymphoblastic leukemia receiving l-asparaginase.
    Strickler N; Balabanov S; Casauro K; Schanz U; Manz MG; Gerber B
    Leuk Lymphoma; 2018 Apr; 59(4):855-862. PubMed ID: 28728499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcome of pediatric patients with acute lymphoblastic leukemia/lymphoblastic lymphoma with hypersensitivity to pegaspargase treated with PEGylated Erwinia asparaginase, pegcrisantaspase: A report from the Children's Oncology Group.
    Rau RE; Dreyer Z; Choi MR; Liang W; Skowronski R; Allamneni KP; Devidas M; Raetz EA; Adamson PC; Blaney SM; Loh ML; Hunger SP
    Pediatr Blood Cancer; 2018 Mar; 65(3):. PubMed ID: 29090524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allergic-like reactions to asparaginase: Atypical allergies without asparaginase inactivation.
    Kloos RQ; Pieters R; Escherich G; van der Sluis IM
    Pediatr Blood Cancer; 2016 Nov; 63(11):1928-34. PubMed ID: 27376478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.